MNTA - In the same call they said they were presently conducting 2 additional Phase I's (a MAD study and drug interaction study) so that is where I would imagine the better part of the 100 patient figure you came up with is coming from.
>MNTA – Their Oct 11 PR mentioned that "over 100" patients had been dosed with M118 as of that date...<
Actually, the 11-Oct PR said over 100 volunteers had participated in M118 clinical trials to date. There’s a difference between volunteers and patients!
-- To reiterate a prior post: the main reason the M118 phase-2 trial will take longer to enroll than you expected is that not all of the approximately 30 clinical centers to be used in the trial will be opened at the outset. Regards, Dew
Market Data 
Markets 
AI
